← Browse by Condition

Medical Condition

head and neck cancer

Total Trials

42

Recruiting Now

42

Trial Phases

Phase 1, Phase 2, Phase 1, Phase 3

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

Oslo University Hospital

NCT06919666 Phase 1, Phase 2

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

University of Colorado, Denver

NCT05200650 Phase 1

A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor

IntraGel Therapeutics

NCT04178174 Phase 3

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Centre hospitalier de l'Univer...

Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation

Circulating Immunes Cells, Cytokines and Brain Radiotherapy

Centre Francois Baclesse

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

University Hospital, Essen

Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy

NCT05076760 Phase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT04842162 Phase 2

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery

Belgium, France

Gustave Roussy, Cancer Campus,...

Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing Radiotherapy

West China Hospital

Training Swallowing Initiation During Expiration

Northwestern University

Early Feeding After Oral Cavity Reconstruction

Icahn School of Medicine at Mo...

Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection

Matthew Spector

Effect of Prehabilitation on Head and Neck Cancer Patients

Laura Deborah Locati

NCT05526924 Phase 1

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

University of Chicago

Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)

University of California, Davi...

Impact in Head and Neck Oncology of Support by a Nurse in the Patient's Care Pathway

University Hospital, Toulouse

An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy

The University of Hong Kong

Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis

Nanfang Hospital, Southern Med...

Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer

Eye & ENT Hospital of Fudan Un...

NCT04729543 Phase 1, Phase 2

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

Erasmus Medical Center

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy

Maastricht Radiation Oncology

NCT06952868 Phase 2

Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers

China Medical University Hospi...

NCT07209189 Phase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Sidney Kimmel Comprehensive Ca...

NCT06725368 Phase 2

Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Centre Paul Strauss

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Hospices Civils de Lyon

NCT06580002 Phase 2

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

University of California, Irvi...

NCT06549946 Phase 1, Phase 2

Ixovex-1 Single Agent and Combination Therapy

NCT06761937 Phase 1

Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients

Erasmus Medical Center

NCT07278557 Phase 2

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia

UNC Lineberger Comprehensive C...

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

University of Illinois at Chic...

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Medical University of South Ca...

NCT05358548 Phase 2

ATATcH Alternating Treatment Plans for Advanced Cancer

Rutgers, The State University ...

NLit and Outcomes in HNC Survivor-Caregiver Dyads

University of Kansas Medical C...

NCT04585750 Phase 1, Phase 2

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

United States, Austr...

PMV Pharmaceuticals, Inc

NCT05576974 Phase 2

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

University of Texas Southweste...

Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer

Centre Hospitalier de Valence

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Centre Hospitalier Universitai...

The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery.

Improving Care for Rural Patients With Solid Tumors

University of Colorado, Denver